BCL2 and neoplasm: Senescent tumor cells have upregulated anti-apoptotic and pro-survival molecular pathways, such as Bcl-2 protein family and PI3K/Akt signaling pathway that reinforce resistance to apoptosis (Zhu et al., 2015).